Radiant Innovation Inc. (TPEX:3373)
16.60
0.00 (0.00%)
Aug 26, 2026, 1:30 PM CST
Radiant Innovation Revenue
Radiant Innovation had revenue of 120.51M TWD in the quarter ending June 30, 2026, with 19.55% growth. This brings the company's revenue in the last twelve months to 409.16M, down -2.28% year-over-year. In the year 2025, Radiant Innovation had annual revenue of 387.58M, down -7.84%.
Revenue (ttm)
409.16M
Revenue Growth
-2.28%
P/S Ratio
1.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
790.47M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 387.58M | -32.95M | -7.84% |
| Dec 31, 2024 | 420.53M | 2.03M | 0.49% |
| Dec 31, 2023 | 418.50M | -146.06M | -25.87% |
| Dec 31, 2022 | 564.56M | -420.49M | -42.69% |
| Dec 31, 2021 | 985.04M | -1.63B | -62.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.78B |
| Cowealth Medical Holding | 2.86B |
| Bioptik Technology Incorporation | 912.86M |
| Diamond Biotechnology | 464.63M |
| Health & Life | 400.09M |
| Wiltrom | 314.09M |
| S&S Healthcare Holding | 172.45M |
| PlexBio | 137.57M |